1.60Open1.60Pre Close0 Volume11 Open Interest2.50Strike Price0.00Turnover0.00%IV4.26%PremiumOct 18, 2024Expiry Date1.56Intrinsic Value100Multiplier-2DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.63Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Ocugen Stock Discussion
State Street Corp's Strategic Acquisition of Shares in Ocugen Inc
Ocugen, Inc. Announces Removal of Clinical Hold on Investigational New Drug Application for Ocu200 Phase 1 Clinical Trial
No comment yet